NewsRoom Articles - Page 1263 of 1339

MondayJan 30, 2017 3:30 pm

Microbot Medical, Inc. (NASDAQ: MBOT) Starts Presentation at NobleCon13

Microbot Medical (NASDAQ: MBOT) is a medical device company, engaging in the research, design, development and commercialization of micro-robotics medical technologies. The company’s ViRob and TipCAT platforms consist of micro-robotic technologies, from which the company is developing its product candidates, including the Self-Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH); and a self-propelling, semi-disposable endoscope that is being developed initially for use in colonoscopy procedures. The company was founded in 2010 and is based in Yokneam, Israel. For more information, visit the company’s website at www.microbotmedical.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication,…

MondayJan 30, 2017 3:30 pm

NV5 Global, Inc. (NASDAQ: NVEE) Starts Presentation at NobleCon13

NV5 Global (NASDAQ: NVEE) provides professional and technical engineering, and consulting solutions to public and private sector clients in the infrastructure, energy, construction, real estate and environmental markets in the United States. The company offers infrastructure, engineering and support services, including site selection, design and construction and program management in water resources, transportation, structural engineering, land development, surveying, commissioning, energy performance, power delivery and other service areas; and construction quality assurance services, such as construction materials testing and engineering, geotechnical engineering and consulting, and forensic consulting. For more information, visit the company’s website at www.nv5.com. About NetworkNewsWire NetworkNewsWire (NNW) provides…

MondayJan 30, 2017 3:00 pm

Social Reality, Inc. (NASDAQ: SRAX) Starts Presentation at NobleCon13

Social Reality (NASDAQ: SRAX) is an Internet advertising and platform technology company that provides tools to automate the digital advertising market in the United States, enabling publishers and advertisers to maximize their digital advertising initiatives. The company’s Social Reality Ad Exchange (SRAX) is a real-time bidding sell side and buy side representation technology that assists publishers in delivering their media inventory to the real-time bidding exchanges; SRAX MD, an ad targeting and data platform for healthcare brands, agencies, and medical content publishers; SRAX Social, a social media and loyalty platform that allows brands to launch and manage their social media…

MondayJan 30, 2017 3:00 pm

Energy Fuels, Inc. (NYSE: UUUU) Starts Presentation at NobleCon13

Energy Fuels (NYSE: UUUU) is engaged in the extraction, recovery and sale of uranium and vanadium properties in the United States. The company operates in two segments, ISR Uranium and Conventional Uranium. Its principal properties are located in Utah, Wyoming, Arizona, New Mexico and Colorado. The company owns the Nichols Ranch uranium recovery facility in Wyoming; White Mesa Mill in Utah; and uranium and uranium/vanadium properties and projects in various stages of exploration, permitting, and evaluation. Its White Mesa Mill also recovers vanadium as a co-product of mineralized material produced from certain of its projects in Colorado and Utah, as…

MondayJan 30, 2017 3:00 pm

Uniroyal Global Engineered Products, Inc. (UNIR) Starts Presentation at NobleCon13

Uniroyal Global (OTC: UNIR) develops, manufactures and distributes vinyl coated fabrics products that have applications in the automotive and non-automotive transportation, indoor/outdoor furniture, commercial and hospitality seating, healthcare facilities, athletic equipment, and residential primarily in North America and Europe. The company’s products in the automotive industry are used primarily in seating, door panels, head and arm rests, security shades, and trim components. Its non-automotive applications include outdoor seating for utility and sports vehicles; and sheeting used in medical, nuclear protection, personal protection, moisture barriers, pram and nursery, movie screen, and decorative surface applications. For more information, visit the company’s website…

MondayJan 30, 2017 2:30 pm

Anavex Life Sciences Corp. (NASDAQ: AVXL) Starts Presentation at NobleCon13

Anavex Life Sciences (NASDAQ: AVXL) is a clinical-stage biopharmaceutical company engaged in the development of drug candidates for the treatment of pain, Alzheimer’s disease, other central nervous system diseases, and various cancers. The company’s lead drug candidates include ANAVEX 2-73, a phase IIa clinical trial for the treatment of Alzheimer’s disease; also in preclinical stage to treat Parkinson’s disease. Its preclinical drug candidates include ANAVEX 3-71, which uses ligands that activate sigma-1 and M1 muscarinic receptors to treat Alzheimer’s disease; ANAVEX 1-41, a sigma-1 agonist that protects nerve cells from degeneration or death; ANAVEX 1037 for the treatment of prostate…

MondayJan 30, 2017 2:30 pm

OptimizeRx Corp. (OPRX) Starts Presentation at NobleCon13

OptimizeRx (OTC: OPRX) provides technology solutions for the health care industry. The company offers pharmaceutical manufacturers a direct-to-consumer and/or direct to physician channel for communicating and promoting the company’s products. Its products include SampleMD, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through EMR or e-Prescribe systems to search, print, or electronically dispense directly to patients, as well as a network of pharmacies. For more information, visit the company’s website at www.optimizerx.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full…

MondayJan 30, 2017 2:30 pm

RLJ Entertainment, Inc. (NASDAQ: RLJE) Starts Presentation at NobleCon13

RLJ Entertainment (NASDAQ: RLJE) is an entertainment content distribution company primarily in North America, the United Kingdom, and Australia. The company’s titles are distributed in multiple formats including broadcast television (including satellite and cable), theatrical and non-theatrical, DVD, Blu-Ray, digital download, and digital streaming. It owns the OTT branded channels, Acorn TV (British TV) and UMC (Urban Movie Channel). The company targets distinct, premium audiences and urban niche audiences. It grows its proprietary digital channels through development, acquisition, and distribution of exclusive rights of program franchises and feature film content. Through Acorn Media Enterprises, its UK development arm, RLJE owns…

MondayJan 30, 2017 2:30 pm

SeaChange International, Inc. (NASDAQ: SEAC) Starts Presentation at NobleCon13

SeaChange (NASDAQ: SEAC) provides multiscreen video products and services that facilitate the aggregation, licensing, management and distribution of video and television advertising content to cable system operators, satellite operators, and telecommunications and media companies worldwide. The company offers multiscreen video products, including SeaChange Adrenalin, a multiscreen back office platform that enables service providers to manage, monetize and deliver a seamless viewing experience across televisions, personal computers (PCs), tablets, smart phones, and other IP-enabled devices; and SeaChange AssetFlow, which is used to receive, manage, and publish content for on-demand viewing on televisions, tablets, PCs and other consumer devices. For more information,…

MondayJan 30, 2017 2:30 pm

Cellectar Biosciences, Inc. (NASDAQ: CLRB) Starts Presentation at NobleCon13

Cellectar Biosciences (NASDAQ: CLRB) is engaged in the development of targeted phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. It offers CLR 131, a PDC radiotherapeutic product candidate currently being evaluated in a phase I study for the treatment of relapse or refractory multiple myeloma; CLR 125, a cancer-targeting radiotherapeutic is under pre-clinical investigation for the treatment of micrometastatic disease ; CLR 124, a cancer-targeting positron emission tomography (PET) imaging PDC for the selective detection of tumors and metastases in a broad range of cancers; and CLR 1502, a cancer-targeting NIR-fluorophore optical imaging PDC for intraoperative tumor…